ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
5,942.47
1.26%
US Tech 100
20,762.73
1.73%
다우존스 지수
42,732.13
0.80%
Bitcoin
97,994.88
-0.22%
Registration Strip Icon for discussion 같은 생각을 가진 투자자들과 토론할 수 있는 활발한 포럼에서 상호 작용하려면 등록하세요.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. NYSE

  6. Solventum Corporation (SOLV) 시세

Solventum Corporation

Solventum Corporation (SOLV)

SolVBL Solutions Inc
Solvac SA
67.12
1.19
(1.80%)
마감 06 1월 6:00AM
15분 지연
67.00
-0.12
(-0.18%)
시간외 거래: 7:08AM
15분 지연

실시간 토론 및 거래 아이디어: 강력한 플랫폼으로 자신있게 거래하세요.

프리미엄

주요 통계 및 세부정보

가격
67.00
매수가
-
매도가
-
거래량
746,853
65.625 일간 변동폭 67.3299
47.16 52주 범위 76.4306
market_cap
11.575B
전일 종가
65.93
개장가
65.93
최근 거래 시간
25
@
67
마지막 거래 시간
재정 규모
US$ 49,790,263
VWAP
66.6668
평균 볼륨(3m)
892,482
발행 주식
172,754,070
배당수익률
-
주가수익률
16.76
주당순이익(EPS)
4.01
매출
8.24B
순이익
692M

Solventum Corporation 정보

Solventum originates from two words: 'solving' and 'momentum.'Solving' captures the company's dedication to finding breakthrough solutions. The organization will listen closely to health care professionals and never stop solving for them -and the many lives they enhance globally. 'Momentum' symboliz... Solventum originates from two words: 'solving' and 'momentum.'Solving' captures the company's dedication to finding breakthrough solutions. The organization will listen closely to health care professionals and never stop solving for them -and the many lives they enhance globally. 'Momentum' symbolizes swifter, nimbler innovation. As the independent health care company builds on every achievement, large and small, its momentum propels it past barriers, towards breakthroughs. The new name represents how the independent health care company will focus on solving big health care challenges and emphasizes the tremendous impact it can make on the world. 더 보기

섹터
Surgical,med Instr,apparatus
산업
Surgical,med Instr,apparatus
웹사이트
www.solventum.com
본부
Wilmington, Delaware, USA
설립됨
-
Solventum Corporation is listed in the Surgical,med Instr,apparatus sector of the 뉴욕 증권거래소 with ticker SOLV. The last closing price for Solventum was US$65.93. Over the last year, Solventum shares have traded in a share price range of US$ 47.16 to US$ 76.4306.

Solventum currently has 172,754,070 shares in issue. The market capitalisation of Solventum is US$11.39 billion. Solventum has a price to earnings ratio (PE ratio) of 16.76.

SOLV 최신 뉴스

추가 뉴스

Form EFFECT - Notice of Effectiveness

18 12월 2024
Edgar (US Regulatory)

Form POS AM - Post-Effective amendments for registration statement

12 12월 2024
Edgar (US Regulatory)

Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]

11 12월 2024
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

04 12월 2024
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

04 12월 2024
Edgar (US Regulatory)

Form EFFECT - Notice of Effectiveness

03 12월 2024
Edgar (US Regulatory)

Form 424B3 - Prospectus [Rule 424(b)(3)]

03 12월 2024
Edgar (US Regulatory)

Solventum to Participate in the Piper Sandler Healthcare Conference

Solventum to Participate in the Piper Sandler Healthcare Conference PR Newswire ST. PAUL, Minn., Nov. 19, 2024 ST. PAUL, Minn., Nov. 19, 2024 /PRNewswire/ -- Solventum (NYSE: SOLV) announced...

19 11월 2024
PR Newswire (US)

Form S-4 - Registration of securities, business combinations

16 11월 2024
Edgar (US Regulatory)

Solventum Launches First 3D Printed Aligner Attachments to Revolutionize Aligner Treatment

Solventum Launches First 3D Printed Aligner Attachments to Revolutionize Aligner Treatment PR Newswire ST. PAUL, Minn., Nov. 14, 2024 Clarity Precision Grip Attachments are fully cured...

14 11월 2024
PR Newswire (US)
기간변동변동 %시가고가저가평균 일일 거래량VWAP
10.450.67618332081166.5567.565.42554195266.16840823CS
4-2.55-3.6664270309169.5571.3965.42571733068.00730386CS
12-1.25-1.831501831568.2576.430665.42589248270.55818488CS
2615.3729.769513848551.6376.430647.16111255464.36452233CS
52-2.15-3.1091829356569.1576.430647.16156799362.8988325CS
156-2.15-3.1091829356569.1576.430647.16156799362.8988325CS
260-2.15-3.1091829356569.1576.430647.16156799362.8988325CS

SOLV - Frequently Asked Questions (FAQ)

What is the current Solventum share price?
The current share price of Solventum is US$ 67.00
How many Solventum shares are in issue?
Solventum has 172,754,070 shares in issue
What is the market cap of Solventum?
The market capitalisation of Solventum is USD 11.39B
What is the 1 year trading range for Solventum share price?
Solventum has traded in the range of US$ 47.16 to US$ 76.4306 during the past year
What is the PE ratio of Solventum?
The price to earnings ratio of Solventum is 16.76
What is the cash to sales ratio of Solventum?
The cash to sales ratio of Solventum is 1.41
What is the reporting currency for Solventum?
Solventum reports financial results in USD
What is the latest annual turnover for Solventum?
The latest annual turnover of Solventum is USD 8.24B
What is the latest annual profit for Solventum?
The latest annual profit of Solventum is USD 692M
What is the registered address of Solventum?
The registered address for Solventum is 251 LITTLE FALLS DRIVE, WILMINGTON, DELAWARE, 19808
What is the Solventum website address?
The website address for Solventum is www.solventum.com
Which industry sector does Solventum operate in?
Solventum operates in the SURGICAL,MED INSTR,APPARATUS sector

이동자

모두 보기
  • 가장 활성
  • % 상승자
  • % 패자
기호가격볼륨
STEMStem Inc
US$ 1.20
(54.74%)
80.12M
KUKEKuke Music Holding Limited
US$ 0.633
(44.55%)
3.9M
BPTBP Prudhoe Bay Royalty Trust
US$ 0.7265
(30.67%)
559.26k
OKLOOklo Inc
US$ 27.22
(24.58%)
23.73M
JOBYJoby Aviation Inc
US$ 9.76
(20.64%)
28.7M
CCMConcord Medical Services Holdings Ltd
US$ 4.50
(-30.23%)
122.16k
ALURAllurion Technologies Inc
US$ 7.675
(-26.41%)
191.08k
RCSPIMCO Strategic Income Fund Inc
US$ 5.74
(-24.17%)
1.93M
PCMPCM Fund Inc
US$ 6.70
(-13.77%)
456.62k
PERFPerfect Corp
US$ 2.56
(-12.33%)
315.91k
STEMStem Inc
US$ 1.20
(54.74%)
80.12M
FFord Motor Company
US$ 9.885
(2.44%)
76.3M
QBTSD Wave Quantum Inc
US$ 9.135
(-4.94%)
63.69M
ACHRArcher Aviation Inc
US$ 11.4825
(19.98%)
54.89M
ABEVAmbev SA
US$ 1.7697
(-3.30%)
51.95M

SOLV Discussion

게시물 보기
DewDiligence DewDiligence 2 월 전
SOLV 3Q24 Results by Business Segment
%Corp YoY Growth
Segment Sales Organic Sales†
Medical/surgical* 57% +1%
Dental 15% -4%
Health-info systems 16% +2%
Purification/filtration 11% 0% †Excludes acquisitions, divestitures, and currency.

*Includes components for other companies’ medical devices.
👍️0
DewDiligence DewDiligence 2 월 전
SOLV reports 3Q24 results—raises 2024 guidance…

New 2024 guidance is as follows:

• Non-GAAP EPS of $6.50-6.65 (vs prior guidance of $6.30-6.50).

• Organic sales growth of 0.5-1.0% (vs prior guidance of 0-1%).

• FCF of $750-850M (vs prior guidance of $700-800M).

At the current share price (~$77 as I’m typing), the midpoint of the new 2024 non-GAAP EPS guidance range represents a P/E ratio of 11.7x.


PR:
https://investors.solventum.com/image/2024-11-07-Solventum-Reports-Third-Quarter-2024-Financial-Results-and-Raises-Full-Year-Guidance.pdf

CC slides:
https://investors.solventum.com/image/SOLV+Q3+2024+Earnings+Presentation.pdf
👍️0
DewDiligence DewDiligence 2 월 전
SOLV seeking buyer for filtration business, according to WSJ sources:

https://www.wsj.com/business/deals/recent-3m-spinoff-explores-sale-of-filtration-unit-f331a83d

In 2Q24, the filtration segment comprised 12% of SOLV’s sales, but the growth rate was non-existent (#msg-174889792).
👍️0
DewDiligence DewDiligence 3 월 전
SOLV hires CMO:

https://finance.yahoo.com/news/solventum-names-surgeon-diagnostics-pioneer-130000072.html
👍️0
DewDiligence DewDiligence 5 월 전
SOLV 2Q24 CC slides:

https://investors.solventum.com/image/Q2+2024+Earnings+Presentation+-+FINAL+8.8.24.pdf
👍️0
DewDiligence DewDiligence 5 월 전
SOLV 2Q24 Results by Business Segment
%Corp YoY Growth
Segment Sales Organic Sales†
Medical/surgical* 56% +2%
Dental 16% -2%
Health-info systems 16% +4%
Purification/filtration 12% -1% †Excludes acquisitions, divestitures, and currency.

*Includes components for other companies’ medical devices.
👍️0
DewDiligence DewDiligence 5 월 전
SOLV’s raised 2024 guidance is as follows:

https://finance.yahoo.com/news/solventum-reports-second-quarter-2024-200500242.html

• 2024 organic sales growth of 0-1% (up from the prior range of -2% to 0%).

• 2024 non-GAAP EPS of $6.30-6.50 (up from the prior range of $6.10-6.40).

At the current share price ($60.00 as I’m typing), the midpoint of the new 2024 non-GAAP EPS guidance range represents a P/E ratio of 9.4x.
👍️0
abrooklyn abrooklyn 5 월 전
Solventum Reports Second Quarter 2024 Financial Results and Raises Full-Year Guidance

Source: PR Newswire (US)
Separation activities and business continuity on track
Reported sales increased 0.2% to $2.081 billion; organic sales increased 1.3%
GAAP Earnings Per Share (EPS) of $0.51; adjusted EPS1 of $1.56
Generated $355 million in cash from operations; free cash flow1 of $297 million
Raises full-year 2024 organic sales growth and adjusted EPS guidance
ST. PAUL, Minn., Aug. 8, 2024 /PRNewswire/ -- Solventum (NYSE: SOLV) today reported financial results as a stand-alone company for the second quarter ended June 30, 2024.

Solventum Logo (PRNewsfoto/3M Healthcare US Opco LLC)

"As we continue to execute a complex transformation, we're encouraged by our first financial results as an independent company and early ability to maintain business continuity," said?Bryan Hanson, chief executive officer, Solventum. "We are starting from a solid foundation and remain focused on addressing historical underperformance and spin-related topics to unlock significant value creation over time."
👍️ 1
DewDiligence DewDiligence 5 월 전
Activist_investor_builds_stake_in SOLV—(3M’s healthcare spinoff):

https://finance.yahoo.com/news/peltz-trian-building-stake-3m-230900848.html
👍️0
DewDiligence DewDiligence 6 월 전
SOLV 1Q24 Results by Business Segment
%Corp YoY Growth
Segment Sales (const currency)
Medical/surgical* 56% flat
Dental 17% flat
Health-info systems 16% flat
Purification/filtration 12% +7% *Includes components for other companies’ medical devices.
👍️0
DewDiligence DewDiligence 6 월 전
SOLV’s “AI play”—>heath-information systems segment:

https://finance.yahoo.com/news/solventum-introduces-denials-prevention-solution-130000721.html

Heath-information systems comprised 16% of SOLV’s overall (pro forma) sales in 1Q24 (#msg-174387294), but SOLV expects this figure to steadily increase due to the application of AI.
👍️0
KingOfSwing...Trading KingOfSwing...Trading 7 월 전
Thank for the excellent post. Very useful.
👍️0
DewDiligence DewDiligence 8 월 전
SOLV reports pro forma 1Q24 results—reiterates 2024 guidance:

https://finance.yahoo.com/news/solventum-reports-first-quarter-2024-105000516.html

SOLV was spun out of 3M on 4/1/24, so the 1Q24 financial results are pro forma based on what SOLV would have reported if it had it been an independent company.

SOLV re-iterated 2024 guidance given on 3/19/24—see #msg-174067513. (2024 guidance includes the pro forma financials for 1Q24 and actual SOLV results for the remainder of the year.)

The only consequential update is that SOLV is not initiating a dividend, so that free cash flow can be directed toward paying down debt. This decision is not surprising in light of the large debt load SOLV took on as part of the spinoff from 3M.

p.s. No 1Q24 CC due to the Investor Day webcast just a few weeks ago.
👍️0
Porgie Tirebiter Porgie Tirebiter 9 월 전
All of a sudden, I own shares of SOLV! I guess I should have been paying more attention to 3M.

I've had 3M for years and years, just collecting the dividend and probably not paying enough attention to it!
👍️0
DewDiligence DewDiligence 9 월 전
SOLV begins trading on NYSE following completion of spinoff from 3M:

https://finance.yahoo.com/news/solventum-begins-trading-york-stock-103000676.html
👍️ 1
DewDiligence DewDiligence 10 월 전
SOLV Investor Day CC slides:

https://d1io3yog0oux5.cloudfront.net/_7984eceea22d0dd69e55aae6e648ee7c/3m/db/3194/30840/presentation/Solventum+Investor+Day+3.19.2024.pdf
👍️ 1
DewDiligence DewDiligence 10 월 전
SOLV issues 2024 guidance:

https://finance.yahoo.com/news/solventum-hosts-inaugural-investor-day-103000871.html

• Organic revenue growth of -2% to 0%

• Adjusted earnings per share (EPS) of $6.10 to $6.40

• Free cash flow of $700M to $800M
👍️ 1
DewDiligence DewDiligence 10 월 전
Details of 3M’s SOLV spinoff finalized:

https://finance.yahoo.com/news/3m-board-directors-approves-spin-165500127.html

3M shareholders of record on 3/18/24 will receive 1 share of SOLV for every 4 shares of 3M. The SOLV shares will be distributed before the market open on 4/1/24.

This is a tax-exempt distribution for US residents.
👍️0
DewDiligence DewDiligence 10 월 전
SOLV sells $6.9B of debt in six tranches:

• $1B of 3yr notes @5.45%

• $1.5B of 5yr notes @5.40%

• $1B of 7yr notes @5.45%

• $1.65B of 10yr notes @5.60%

• $1.25B of 30yr notes @5.90%

• $0.5B of 40yr notes @6.00%

The total debt issuance was supposed to $8.4B (according to 3M's recent webcast), but I don't know where the other $1.5B is coming from.

All but $600M of the proceeds will be paid to 3M as consideration for the spin-off of 3M’s healthcare business to SOLV.
👍️ 1
DewDiligence DewDiligence 10 월 전
SOLV is holding an Investor Day webcast 3/19/24 at 9am ET.
👍️0
DewDiligence DewDiligence 10 월 전
These are the five focal areas for 3M’s healthcare business that will become part of Solventum; they comprise about 25% of 3M’s current company-wide sales:

https://engage.3m.com/purification

https://www.3m.com/3M/en_US/health-information-systems-us/

https://www.3m.com/3M/en_US/medical-us/ (surgical supplies and wound care)

https://www.3m.com/3M/en_US/medical-device-components-us/ (components for other companies’ medical devices)

https://www.3m.com/3M/en_US/oral-care-us/ (dentistry and othodontics)
👍️0
DewDiligence DewDiligence 10 월 전
Further details of 3M/SOLV capitalization:

SOLV will sell $8.4B of new debt, keeping $600M of the proceeds and paying $7.7B as a one-time (tax-free) dividend to 3M. (~$100M of the debt proceeds will go to underwriting fees.)

After the debt issuance and one-time payment to 3M, SOLV will have a debt/EBITDA ratio of ~3.5.
👍️0
DewDiligence DewDiligence 10 월 전
3M sets 4/1/24 date for Solventum spin-off:

https://d1io3yog0oux5.cloudfront.net/_28c5051c41e86ce7771a2dfe11a5ee94/3m/news/2024-02-21_3M_Announces_Filing_of_Form_10_Registration_1826.pdf
👍️0

최근 히스토리

NYSE
SOLV
Solventum
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

대한민국
회사 소개
사업
Popular
앱 받기
App Store
Google Play

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2025 ADVFN PLC - 모든 권리 보유